BRISBANE, Australia, Dec. 5, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has today announced the ...

TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ...

A Aaaaaaaaaaaa Aaaa 1,524.0 +33.13% 2,028.9 ...

CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in ...

Brisbane-based Microbio, the creator of a rapid sepsis blood test, entered voluntary administration in May after burning through its cash reserves and posting heavy operating losses during its ...

Microbio has developed a pathogen test to help identify “a silent killer” that is notoriously difficult to predict, diagnose and treat. Brisbane medtech scale-up Microbio has developed a game-changing ...

Microbio (4128) has delivered a -25.92% change over the past year, with a 52-week range between 14.20 and 27.50. What Is the Average Daily Trading Volume of Microbio (4128)? The average daily trading ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, ...

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and ...

Visit a quote page and your recently viewed tickers will be displayed here.